MARKET

BCTXW

BCTXW

BRIACELL THER
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.950
+0.950
+23.75%
After Hours: 5.69 +0.74 +14.95% 17:36 09/24 EDT
OPEN
3.500
PREV CLOSE
4.000
HIGH
5.20
LOW
4.100
VOLUME
386.46K
TURNOVER
--
52 WEEK HIGH
5.20
52 WEEK LOW
0.6400
MARKET CAP
--
P/E (TTM)
-4.9303
1D
5D
1M
3M
1Y
5Y
BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com
BriaCell Therapeutics CEO Interview BriaCell Therapeutics CEO Emphasizes Recent Key Developments in Audio Interview with SmallCapVoice.com AUSTIN, Texas, Sept. 23, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new ...
GlobeNewswire · 1d ago
BRIEF-BriaCell Announces TSXV Acceptance Of Normal Course Issuer Bid
reuters.com · 2d ago
BriaCell Announces TSXV Acceptance of Normal Course Issuer Bid
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, today announces that the TSX Venture Exchange (the "TS...
GlobeNewswire · 2d ago
BriaCell to Present at the Benzinga Healthcare Small Cap Conference September 29-30
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces today that the Company will be presenting at...
GlobeNewswire · 09/16 13:00
BRIEF-Briacell To Buy Back Up To 10% Of Common Shares, 10% Of Listed Warrants
reuters.com · 09/09 14:06
BriaCell Announces Securities Buyback to Purchase up to 10% of Common Shares and up to 10% of Listed Warrants
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces that its board of directors (the "Board") ha...
GlobeNewswire · 09/09 13:00
BRIEF-Briacell Therapeutics Appoints Marc Lustig To Board Of Directors
reuters.com · 09/01 13:17
BriaCell Therapeutics Appoints Marc Lustig to its Board of Directors
BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX-V: BCT) ("BriaCell" or the "Company"), a clinical-stage biotechnology company specializing in targeted immunotherapies for advanced breast cancer, announces the appointment of Mr. Marc Lustig to the Co...
GlobeNewswire · 09/01 13:15
More
Forecast
No Data
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of BCTXW. Analyze the recent business situations of BRIACELL THER through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
  • All
  • Financials
  • Insiders
No Data
About BCTXW
BriaCell Therapeutics Corp. is a Canada-based immuno-oncology focused biotechnology company developing targeted approaches for the management of cancer. The Company, in collaboration with Incyte Corporation, is conducting a Phase I/IIa clinical trial of Bria-IMT in combination with Incyte drugs, INCMGA00012 and epacadostat, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy, for advanced breast cancer. Bria-OTS immunotherapy treatments are personalized to match the patient without the need for personalized manufacturing. Bria-OTS is designed to produce a potent and selective immune response against the cancer of each patient while eliminating the time, expense and manufacturing logistics associated with other personalized immunotherapies.

Webull offers kinds of Briacell Therapeutics Corp stock information, including NASDAQ:BCTXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCTXW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BCTXW stock methods without spending real money on the virtual paper trading platform.